ASML’s Asian Strategy: Balancing Korean Expansion Against Chinese Headwinds

ASML, the semiconductor equipment leader, is navigating contrasting fortunes across Asia. While the company is strengthening its foothold in South Korea with a major new investment, it simultaneously faces a looming downturn in its crucial Chinese market. This divergence presents a significant challenge: can the tech giant successfully offset an anticipated contraction in China with growth from other regions, or will its share price face substantial pressure?

Solid Financials Mask Emerging Geographical Risks

The company’s current financial performance remains robust, providing a buffer against future uncertainties. For the third quarter of 2025, ASML reported net earnings of €2.1 billion on revenues totaling €7.5 billion. Management maintains its full-year 2025 outlook, projecting revenue growth of approximately 15%. However, the pivotal guidance for 2026 reveals the underlying tension: executives anticipate a “normalization” of sales to China beginning that year, yet believe overall revenues can remain stable as other markets compensate for the expected shortfall. This is particularly significant given that China contributed 42% of total sales in Q3 2025, establishing itself as a primary growth driver.

Should investors sell immediately? Or is it worth buying Asml?

Strategic Korean Investment Counters Chinese Exposure

In a strategic move to diversify its regional dependencies, ASML is establishing a new $182 million campus in Hwaseong, South Korea. This advanced hub, featuring a repair center and a global training facility, is designed to enhance support for key Asian clients such as Samsung and SK Hynix. This expansion underscores a deliberate effort to deepen roots in South Korea’s high-tech ecosystem, creating a strategic counterweight to the projected sales deceleration in China. The substantial investment signals confidence in the long-term growth trajectory of the Korean semiconductor industry.

Investor Sentiment and the 2026 Litmus Test

Market participants have thus far reacted with cautious restraint. Although ASML shares declined by 1.6% on Tuesday, the trading volume was notably below average. This subdued activity suggests many investors are adopting a wait-and-see approach rather than making decisive portfolio adjustments. Currently trading around €882, the stock sits roughly 5% below its annual peak. The true test, however, awaits in 2026. The company’s ability to seamlessly navigate the expected Chinese downturn and execute on its geographical rebalancing act will ultimately determine whether the current share price stability is justified or if a more severe correction lies ahead.